Vista Wealth Management Group, LLC Nektar Therapeutics Transaction History
Vista Wealth Management Group, LLC
- $1.47 Billion
- Q1 2025
A detailed history of Vista Wealth Management Group, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Vista Wealth Management Group, LLC holds 51,500 shares of NKTR stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,500
Previous 51,500
-0.0%
Holding current value
$3.03 Million
Previous $47,000
25.53%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
19Shares Held
16.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY15.2MShares$893 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY491KShares$28.9 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$19.3 Million0.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO12KShares$707,0400.0% of portfolio
-
Ropes Wealth Advisors LLC Boston, MA11.6KShares$682,2930.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $11B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...